Look for:

Our offer for

CENTOGENE NV COM EUR0.12


ISIN:
NL0014040206
WKN:
N1976T109

2024/06/14 22:26:42
Price
0.361 EUR
Difference 4.03% (0.01)

General attributes

ISINNL0014040206
SymbolCNTG
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)10 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)0.348 EUR (4,443)
Ask (Ask size)0.3735 EUR (4,123)
Open0.385 EUR
High0.385 EUR
Low0.3605 EUR
Close (prev. day)0.347 EUR
VWAP0.38172 EUR
Volume (pcs)2,756
Trading volume1,052.01
Number of trades4
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: CENTOGENE NV COM EUR0.12PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/06/14 22:26:42
Price
0.361 EUR
Difference 4.03% (0.01)

General attributes

ISINNL0014040206
SymbolCNTG
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)10 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)0.348 EUR (4,443)
Ask (Ask size)0.3735 EUR (4,123)
Open0.385 EUR
High0.385 EUR
Low0.3605 EUR
Close (prev. day)0.347 EUR
VWAP0.38172 EUR
Volume (pcs)2,756
Trading volume1,052.01
Number of trades4
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-67.33%-51.22%-95.86%
Perf (abs.)-0.74-0.38-8.36
Beta0.451.030.69
Volatility75.1690.0695.29
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.345 EUR (826)
Ø price 30 days | Ø volume 30 days (pcs.)0.359 EUR (7,374)
Ø price 100 days | Ø volume 100 days (pcs.)0.600 EUR (5,289)
Ø price 250 days | Ø volume 250 days (pcs.)0.885 EUR (3,466)
YTD High | date1.195 EUR (2024/01/18)
YTD Low | date0.315 EUR (2024/06/10)
52 Weeks High | date1.830 EUR (2023/06/28)
52 Weeks Low | date0.315 EUR (2024/06/10)

All listings for CENTOGENE NV COM EUR0.12

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/06/1420:300.351 EUR0.0019
Duesseldorf2024/06/1419:300.358 EUR0.007
Frankfurt2024/06/1408:040.34 EUR0.002
Hamburg2024/06/1408:160.34 EUR0.003
Munich2024/06/1408:040.3605 EUR0.002
Nasdaq2024/06/1422:300.3707 USD0.0166
Stuttgart2024/06/1417:490.322 EUR0.006
Tradegate2024/06/1422:260.361 EUR0.004

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=142389&ID_TYPE_IMAGE_LOGO=2

Contact Details

CENTOGENE NV
- -
Am Strande 7 - 18055 Rostock
Telefon: +49-381-80113400
Fax: +381-80113401
E-mail: -

PDF Downloads

Company report: CENTOGENE NV COM EUR0.12PDF Download

Company Profile

Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.

Members of Management Board

Kim StrattonChairman of Managing Board
Ian RentschMember of Executive Committee
Miguel Coego RiosMember of Executive Committee
Peter BauerMember of Executive Committee

Board of directors

Peer SchatzChairman of Supervisory Board
Eric SouêtreMember of Supervisory Board
Hubert BirnerMember of Supervisory Board
Jonathan SheldonMember of Supervisory Board
Guido PrehnMember of Supervisory Board
Mary SheahanMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer